The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index; 43 of the 89 sources its claims cite were checked for support.
A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics
Open accessAbstract
Translating preclinical safety findings into reliable insights for human risk assessment remains a fundamental challenge in drug development. Prior preclinical-clinical concordance studies have been constrained by limited drug coverage, reliance on identical-term matching for adverse events (AEs), and limited consideration of species, modality, exposure, and biological or mechanistic context. To address these gaps, we assembled a large cross-species concordance dataset, integrating standardized preclinical and clinical safety data for 7,565 marketed and investigational drugs from PharmaPendium and OFF-X. Our framework employs likelihood ratios to reduce prevalence bias and extends concordance assessment beyond identical-term matches to include semantically and mechanistically related AE pairs. Stratified analyses by species, modality, and exposure-matched subsets further refined translational relevance, while integration of on- and off-target annotations supports mechanistic interpretation and potential screening. Using this approach, we identified 850 significant identical-term AEs and 2,833 additional unique endpoints from cross-term associations. To promote reproducibility and transparency in animal research, we provide open access to the analytic code and statistical results via an interactive web application. An accompanying multi-agent AI system (ToxAgents) enables standardized querying and interpretation of concordance results. Together, these resources extend previous foundational efforts and establish a shared, data-driven platform to advance translational safety science, support evidence-based study design aligned with the 3Rs principles, and ultimately contribute to the development of safer medicines to improve human health.
Overview
CoChat Summary
TL;DR
This study assembled a harmonized cross-species safety dataset for 7,565 marketed and investigational drugs from PharmaPendium and OFF-X and used likelihood ratios, species/modality/exposure stratification, and cross-term mapping to assess preclinical-to-human toxicity concordance. It identified 850 significant identical-term adverse events and 2,833 additional unique endpoints, with generally low-to-moderate organ-system concordance but stronger phenotype-level signals, and released a web app plus the ToxAgents multi-agent AI system.
Key findings
- Across all modalities, 850 significant identical-term phenotypes were identified, including 780 for small molecules, 237 for biologics, and 94 in the exposure-controlled subset; cross-term analysis added 2,833 unique endpoints (2,375 clinical, 854 preclinical, 396 shared).
- At the SOC level, “infections and infestations” had the highest predictivity (LR+ >10) for both small molecules and biologics, followed by immune, renal/urinary, and musculoskeletal disorders with moderate LR+ <5; nervous system, psychiatric, investigations, general disorders, and pregnancy/perinatal conditions showed low LR+. Monkeys had higher median LR+ (SM 4.18, Bio 3.74) than other species, and most iLR– values were close to 1.
- At the PT level, small-molecule examples included constipation (LR+ = 21.5), rash (20.0), neutropenia (16.1), and anemia (10.1); biologic examples included infection (116.0), rash (45.2), hyperglycemia (34.4), and neutropenia (21.8). In hepatobiliary/metabolic analyses, immune-mediated hepatitis (321.8), hyperinsulinemia (217.7), and hypertriglyceridemia (113.1) were highly concordant, whereas nonspecific terms such as hepatotoxicity (2.2), hepatic function abnormal (4.2), and liver disorder (3.2) were poor.
- Compared with Giblin et al., 183 of 188 (97%) significant AEs were also significant in this dataset, with Pearson r = 0.61–0.88 across PPV, NPV, LR+, and iLR–; 70% of AEs with LR+ ≥10 in the prior study also met that threshold here. Cross-term semantic similarity quartiles showed median LR+ increasing from 5.6 to 6.7 (Kruskal–Wallis p = 1.8 × 10−100).
Methods
- Data were compiled from PharmaPendium and OFF-X, with AEs coded in MedDRA; 13,949 unique AE terms were retrieved, then filtered to 7,565 drugs with at least one AE in both preclinical and clinical studies. Preclinical species were mouse, rat, rabbit, dog, and monkey; drugs were categorized as small molecule or biologic. Exposure-controlled comparisons required |Δlog10Cmax| or |Δlog10AUC| ≤1.
- Concordance used 2 × 2 contingency tables, two-tailed Fisher’s Exact Test with Bonferroni correction within each SOC (adjusted p < 0.05), and likelihood ratios (LR+, iLR–) plus PPV and NPV. Identical-term and non-identical within-SOC AE pairs were assessed; OpenAI text-embedding-3 cosine similarity quantified semantic relatedness.
- Mechanistic annotation used DrugBank and OFF-X on/off-targets, gprofiler with DisGeNET, STRING PPI networks, and MCODE. Results were made accessible via a Shiny web app and ToxAgents, a GPT-4.1/RAG multi-agent system using 26 ICH safety documents, with case studies and reproducibility/robustness checks.
Limitations
- The paper states that source-data assignment of MedDRA terms, especially for preclinical behaviors or nuanced histopathology, may be subjective or inconsistent; missing AEs due to incomplete/selective reporting or extraction failure may mask translational signals, and OFF-X investigational-drug AEs may be neutral or lack severity because companies may not disclose more impactful findings.
- The paper states that AEs are encoded as binary present/absent outcomes without frequency, severity, or explicit dose-response data, limiting use for clinical risk thresholds; biologics were not subtyped because current sources lack consistent subtype labels.
- The paper states that target annotation can be confounded by complex pharmacology, multiple on- and off-targets, metabolites, or uncharacterized off-target interactions; it also notes that true negative counts are estimations because not all possible observations were measured or reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
30 Valid · 3 Not valid · 23 Not checked · 160 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Advancing drug safety assessment relies on bridging the translation gap between animal toxicology findings and clinical outcomes, a challenge with far-reaching consequences for R&D efficiency, regulatory success and patient safety (Waring et al., 2015; Amorim et al., 2024).”
§ A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics > Introduction
What the sources say
- Not checked — no full text of the sourcecites Waring et al., 2015 source
- Supportedcites Amorim et al., 2024 source
The Introduction states that extrapolating animal data to humans is not always straightforward because of species differences, and reports limited agreement between animal-model toxicity predictions and human outcomes. It also links toxicity prediction to drug-development costs and safety, and notes that drugs must meet regulatory safety standards. No page numbers are provided in our copy. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The absence of pharmacokinetic exposure control further confounds interpretation, as toxicities observed in animal models, often at high doses, may not accurately represent risks relevant to clinical settings with relevant efficacious doses (Van Norman, 2019).”
§ A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics > Introduction
What the sources say
- Partly supportedcites Van Norman, 2019 sourceExperimental — accuracy not yet measured
The Historical Perspective section reports poor concordance between animal and human toxicity findings. But our copy does not identify a lack of pharmacokinetic exposure control as the confounder or say that toxicities seen in animals at high doses may be irrelevant at clinically efficacious doses. The Price of Wrong Decisions instead gives examples of animals appearing safe at doses far above those that harmed humans; no page numbers were provided. (LLM, conf=0.83)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“which may relate to differences in immune status, microbial exposure, and the scopes of behavioral assessments between animals and humans (Dinan and Cryan, 2017; Huggins et al., 2019; Burger et al., 2023).”
§ A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics > Results and discussions > SOC-based AE frequency and concordance analysis
What the sources say
- Partly supportedcites Dinan and Cryan, 2017 sourceExperimental — accuracy not yet measured
The Future Research Directions section says that complex human gut microbial ecosystems are difficult to mimic and that translational investigations lag behind preclinical studies. It does not say that infections and psychiatric disorders are underrepresented in animal studies, or attribute such underrepresentation to differences in immune status, microbial exposure, or the scope of behavioral assessments. No page numbers are available in our copy. (LLM, conf=0.76)
- Supportedcites Huggins et al., 2019 source
The Introduction explains that laboratory mice have limited microbial exposure compared with humans and that this difference matters when using mice to study immune fitness. The Discussion adds that SPF housing leaves laboratory mice with an underdeveloped immune system unlike that of adult humans. These passages support the immune-status and microbial-exposure differences for which Huggins et al. is cited; the other citations accompany the behavioral-assessment aspect. (LLM, conf=0.88)
- Partly supportedcites Burger et al., 2023 sourceExperimental — accuracy not yet measured
The Abstract and Discussion report that pathogen-free laboratory mice have different microbial exposure and immune development from mice raised with diverse microbes, supporting the immune-status and microbial-exposure explanation. The paper does not address psychiatric disorders or differences in the scope of behavioral assessments between animals and humans. No page numbers are available in our copy. (LLM, conf=0.86)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Analytical inconsistencies also arise from the use of different statistical frameworks such as sensitivity, specificity, predictive values, or likelihood ratios, which can yield divergent conclusions (Monticello et al., 2017; Bailey and Balls, 2019; Giblin et al., 2021).”
§ A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics > Introduction
What the sources say
- Not checked — no full text of the sourcecites Monticello et al., 2017 source
- Supportedcites Bailey and Balls, 2019 source
In the main-text section “Monticello et al.” (page unavailable), Bailey and Balls say Monticello et al. relied chiefly on negative predictive value to support animal testing, whereas examining the likelihood ratios yields a different assessment. The paper also explains that likelihood ratios incorporate sensitivity and specificity, supporting the claim that the choice of statistical metric can affect conclusions. (LLM, conf=0.90)
- Partly supportedcites Giblin et al., 2021 sourceExperimental — accuracy not yet measured
The “Quantifying risk” section says likelihood ratios offer a different, potentially better interpretation of concordance than sensitivity, supporting the point that the choice of metric matters. It does not discuss specificity or predictive values as alternative frameworks, or show that using these metrics yields divergent conclusions. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“This result is consistent with previous reports (Bailey et al., 2014; Clark, 2015; Clark and Steger-Hartmann, 2018).”
§ A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics > Results and discussions > SOC-based AE frequency and concordance analysis
What the sources say
- Not checked — no full text of the sourcecites Bailey et al., 2014 source
- Supportedcites Clark, 2015 source
The Abstract states that the absence of adverse events in nonclinical studies is not a good predictor of safety in humans. This supports the citing sentence’s characterization of Clark (2015) as a previous report consistent with that result. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites Clark and Steger-Hartmann, 2018 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
103 more claims · 13 with their cited sources checked
Create a free account to see all 216 claims and every source verdict.
- Probably not a substantial claim. 53
- It may state two separate claims as one. 79
Citations
Cites
Szklarczyk, D., Kirsch, R., Koutrouli, M., Nastou, K., Mehryary, F., Hachilif, R., Gable, A. L., Fang, T., Doncheva, N. T., Pyysalo, S., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac1000 · Cited by 9,726 · cited 1×
“Protein-protein interaction (PPI) analysis was performed using the STRING database (Szklarczyk et al., 2023) to investigate potential interactions among targets.”
An automated method for finding molecular complexes in large protein interaction networks
Bader, G. D., & Hogue, C. W. (2003) · BMC Bioinformatics · doi:10.1186/1471-2105-4-2 · Cited by 6,072 · cited 1×
“To refine the network and focus on key interactions, the MCODE algorithm (Bader and Hogue, 2003) was applied to identify densely connected sub-networks, which were further analyzed for functional enrichment to determine their biological roles and contributions to toxicity.”
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Postow, M. A., Sidlow, R., & Hellmann, M. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1703481 · Cited by 4,849 · cited 2×
“This is consistent with the strong concordance observed in mice, which are widely used to model T cell–mediated hepatic injury and immune-related AE (Postow et al., 2018; Shojaie et al., 2021).”
Piñero, J., Bravo, À., Queralt-Rosinach, N., Gutiérrez-Sacristán, A., Deu-Pons, J., Centeno, E., García-García, J., Sanz, F., & Furlong, L. I. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw943 · Cited by 2,680 · cited 1×
“Pathway and functional enrichment analyses were conducted in R with gprofiler (Kolberg and Raudvere, 2025), employing the DisGeNET database (Piñero et al., 2017) to explore relevant biological pathways and processes.”
Concordance of the toxicity of pharmaceuticals in humans and in animals
Olson, H., Betton, G., Robinson, D., Thomas, K., Monro, A., Kolaja, G., Lilly, P., Sanders, J., Sipes, G., Bracken, W., et al. (2000) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.2000.1399 · Cited by 2,050 · cited 2×
“Early work by Olson et al. (2000) within the International Life Sciences Institute’s Health and Environmental Sciences Institute (ILSI-HESI) quantified cross-species sensitivity by analyzing 150 drugs (both investigational and approved).”
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450 · cited 1×
“Advancing drug safety assessment relies on bridging the translation gap between animal toxicology findings and clinical outcomes, a challenge with far-reaching consequences for R&D efficiency, regulatory success and patient safety (Waring et al., 2015; Amorim et al., 2024).”
Theriot, C. M., Koenigsknecht, M. J., Carlson, P. E., Hatton, G. E., Nelson, A. M., Li, B., Huffnagle, G. B., Z. Li, J., & Young, V. B. (2014) · Nature Communications · doi:10.1038/ncomms4114 · Cited by 974 · cited 1×
“Similarly, C. difficile colitis is supported by mouse models that recapitulate key clinical and histopathologic features and enable mechanistic studies (Chen et al., 2008; Theriot et al., 2014).”
Neurobiology of food intake in health and disease
Morton, G. J., Meek, T. H., & Schwartz, M. W. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3745 · Cited by 748 · cited 1×
“These clusters point to CNS-mediated appetite regulation involving hypothalamic neurocircuitry and suggest that hyperphagia may reflect direct drug effects on neural and hormonal satiety control (Morton et al., 2014; Zhuang et al., 2017; He et al., 2021; Wang et al., 2024; Qiu and Fu, 2025).”
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 732 · cited 3×
“These events often lack precise analogs in animal models, are subject to broad etiologic variability, or are under-detected due to behavioral and physiological differences across species (Van Norman, 2019; Lu et al., 2023; Wu et al., 2023).”
A mouse model of clostridium difficile-associated disease
Chen, X., Katchar, K., Goldsmith, J. D., Nanthakumar, N., Cheknis, A., Gerding, D. N., & Kelly, C. P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.09.002 · Cited by 510 · cited 2×
“This observation is consistent with established mouse models of antibiotic-induced C. difficile colitis that recapitulate key features of the human disease, supporting the strong translational relevance of this phenotype (Chen et al., 2008; Best et al., 2012).”
GDF15 induces anorexia through nausea and emesis
Borner, T., Shaulson, E. D., Ghidewon, M. Y., Barnett, A. B., Horn, C. C., Doyle, R. P., Grill, H. J., Hayes, M. R., & De Jonghe, B. C. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2019.12.004 · Cited by 255 · cited 1×
“…(OPRM1), gut–brain axis regulators (GLP1R, GDF15), and excitability-related channels (CACNA1A), providing mechanistic support for these translational links (Niesler et al., 2008; Joy Lin et al., 2014; Sugino et al., 2014; Borner et al., 2020; Indelicato and Boesch, 2021; Huang et al., 2024).”
Microbes, immunity, and behavior: psychoneuroimmunology meets the microbiome
Dinan, T. G., & Cryan, J. F. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.103 · Cited by 246 · cited 1×
“…to humans (infections: Bio 10.7%, SM 6.9%; psychiatric disorders: SM 5.4%, Bio 2.2%), which may relate to differences in immune status, microbial exposure, and the scopes of behavioral assessments between animals and humans (Dinan and Cryan, 2017; Huggins et al., 2019; Burger et al., 2023).”
InfluentialBiologics for targeting inflammatory cytokines, clinical uses, and limitations
Rider, P., Carmi, Y., & Cohen, I. (2016) · International Journal of Cell Biology · doi:10.1155/2016/9259646 · Cited by 226 · cited 1×
“These AEs are frequently observed in biologics targeting immune checkpoints, or cytokines (Rider et al., 2016; Postow et al., 2018).”
The role of dopamine signaling in epileptogenesis
Bozzi, Y., & Borrelli, E. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00157 · Cited by 199 · cited 1×
“…GRIN2B, GRIA1), key receptors (DRD1–3, OPRK1, OPRM1) and neuromodulatory signaling modulators (HTR1A, SIGMAR1), all of which are implicated in seizure susceptibility and propagation (López-Meraz et al., 2005; Bozzi and Borrelli, 2013; Vavers et al., 2023; Zhang et al., 2024; Ferraro et al., 2025).”
Törnqvist, E., Annas, A., Granath, B., Jalkesten, E., Cotgreave, I., & Öberg, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101638 · Cited by 198 · cited 3×
“These events often lack precise analogs in animal models, are subject to broad etiologic variability, or are under-detected due to behavioral and physiological differences across species (Van Norman, 2019; Lu et al., 2023; Wu et al., 2023).”
Experimental models of non-alcoholic fatty liver disease in rats
Kucera, O. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8364 · Cited by 195 · cited 1×
“Rats demonstrated high translatability for hypertriglyceridemia (112.7), in line with their known sensitivity to hepatic lipid accumulation and chronic metabolic stress (Boivin and Deshaies, 1995; Kucera and Cervinkova, 2014).”
InfluentialMonticello, T. M., Jones, T. W., Dambach, D. M., Potter, D. M., Bolt, M. W., Liu, M., Keller, D. A., Hart, T. K., & Kadambi, V. J. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.09.006 · Cited by 186 · cited 4×
“For both LR+ and iLR−, values at or below 1 indicate no predictive power, values above 1 demonstrate increasing predictivity, and ratios exceeding 10 are generally considered strong (Clark, 2015; Monticello et al., 2017).”
InfluentialAn analysis of the use of animal models in predicting human toxicology and drug safety
Bailey, J., Thew, M., & Balls, M. (2014) · Alternatives to Laboratory Animals · doi:10.1177/026119291404200306 · Cited by 182 · cited 2×
“This result is consistent with previous reports (Bailey et al., 2014; Clark, 2015; Clark and Steger-Hartmann, 2018).”
RCy3: Network biology using Cytoscape from within R
Gustavsen, J. A., Pai, S., Isserlin, R., Demchak, B., & Pico, A. R. (2019) · F1000Research · doi:10.12688/f1000research.20887.3 · Cited by 175 · cited 1×
“The network was visualized using RCy3 (Gustavsen et al., 2019), an R interface for Cytoscape, to facilitate the interpretation of complex interactions.”
Dissociable hindbrain GLP1R circuits for satiety and aversion
Huang, K.-P., Acosta, A. A., Ghidewon, M. Y., McKnight, A. D., Almeida, M. S., Nyema, N. T., Hanchak, N. D., Patel, N., Gbenou, Y. S. K., Adriaenssens, A. E., et al. (2024) · Nature · doi:10.1038/s41586-024-07685-6 · Cited by 166 · cited 1×
“…(OPRM1), gut–brain axis regulators (GLP1R, GDF15), and excitability-related channels (CACNA1A), providing mechanistic support for these translational links (Niesler et al., 2008; Joy Lin et al., 2014; Sugino et al., 2014; Borner et al., 2020; Indelicato and Boesch, 2021; Huang et al., 2024).”
The rabbit as a model for reproductive and developmental toxicity studies
Foote, R. H., & Carney, E. W. (2000) · Reproductive Toxicology · doi:10.1016/s0890-6238(00)00101-5 · Cited by 164 · cited 1×
“Additionally, the disproportionately high incidence of “pregnancy and perinatal toxicities” observed in rabbits aligns with their common utilization in reproductive toxicology studies (Foote and Carney, 2000; Moxon et al., 2023).”
A big data approach to the concordance of the toxicity of pharmaceuticals in animals and humans
Clark, M., & Steger-Hartmann, T. (2018) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2018.04.018 · Cited by 162
Bremer, A. A., Stanhope, K. L., Graham, J. L., Cummings, B. P., Wang, W., Saville, B. R., & Havel, P. J. (2011) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2011.00298.x · Cited by 148 · cited 1×
“…in lipid metabolism and endocrine regulation, and underscoring the relevance of non-human primates in modeling systemic metabolic responses (Bremer et al., 2011; Friedman et al., FIGURE 5 Network visualization of significant AEs within the hepatobiliary system and metabolism/nutrition…”
Lascelles, B. D. X., Blikslager, A. T., Fox, S. M., & Reece, D. (2005) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2005.227.1112 · Cited by 138 · cited 1×
“For example, drug-induced gastrointestinal perforation has long been modeled in animals, especially dogs, and extensive work on NSAIDs has established reproducible frameworks linking this AE to human (Lascelles et al., 2005; Mabry et al., 2021).”
Models for the study of Clostridium difficile infection
Best, E. L., Freeman, J., & Wilcox, M. H. (2012) · Gut Microbes · doi:10.4161/gmic.19526 · Cited by 135 · cited 1×
“This observation is consistent with established mouse models of antibiotic-induced C. difficile colitis that recapitulate key features of the human disease, supporting the strong translational relevance of this phenotype (Chen et al., 2008; Best et al., 2012).”
Comparison of minipig, dog, monkey and human drug metabolism and disposition
Dalgaard, L. (2015) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2014.12.005 · Cited by 132 · cited 1×
“Additionally, gastrointestinal disorders showed relatively high AE percentages in both dogs and monkeys compared to other species, also highlighting species specific susceptibilities (Al-Saffar et al., 2015; Dalgaard, 2015).”
Amorim, A. M. B., Piochi, L. F., Gaspar, A. T., Preto, A. J., Rosário-Ferreira, N., & Moreira, I. S. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00352 · Cited by 132 · cited 1×
“Advancing drug safety assessment relies on bridging the translation gap between animal toxicology findings and clinical outcomes, a challenge with far-reaching consequences for R&D efficiency, regulatory success and patient safety (Waring et al., 2015; Amorim et al., 2024).”
Indelicato, E., & Boesch, S. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.639994 · Cited by 123 · cited 1×
“…(OPRM1), gut–brain axis regulators (GLP1R, GDF15), and excitability-related channels (CACNA1A), providing mechanistic support for these translational links (Niesler et al., 2008; Joy Lin et al., 2014; Sugino et al., 2014; Borner et al., 2020; Indelicato and Boesch, 2021; Huang et al., 2024).”
Evaluating and mitigating the immunogenicity of therapeutic proteins
Sauna, Z. E., Lagassé, D., Pedras-Vasconcelos, J., Golding, B., & Rosenberg, A. S. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.05.008 · Cited by 118 · cited 1×
“…as immune-mediated organ injury such as checkpoint inhibitor-associated hepatitis, which have been qualitatively recapitulated in preclinical species, particularly in non-human primates and humanized mouse models (Sauna et al., 2018; Yong et al., 2020; Llewellyn et al., 2021; Kroenke et al., 2024).”
Huggins, M. A., Sjaastad, F. V., Pierson, M., Kucaba, T. A., Swanson, W., Staley, C., Weingarden, A. R., Jensen, I. J., Danahy, D. B., Badovinac, V. P., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.028 · Cited by 114 · cited 1×
“…to humans (infections: Bio 10.7%, SM 6.9%; psychiatric disorders: SM 5.4%, Bio 2.2%), which may relate to differences in immune status, microbial exposure, and the scopes of behavioral assessments between animals and humans (Dinan and Cryan, 2017; Huggins et al., 2019; Burger et al., 2023).”
InfluentialEpilepsy-associated genes: an update
Zhang, M., Liang, X., Wang, J., Gao, L., Liao, H.-J., He, Y.-H., Yi, Y., He, N., & Liao, W. (2023) · Seizure · doi:10.1016/j.seizure.2023.09.021 · Cited by 113 · cited 1×
“…GRIN2B, GRIA1), key receptors (DRD1–3, OPRK1, OPRM1) and neuromodulatory signaling modulators (HTR1A, SIGMAR1), all of which are implicated in seizure susceptibility and propagation (López-Meraz et al., 2005; Bozzi and Borrelli, 2013; Vavers et al., 2023; Zhang et al., 2024; Ferraro et al., 2025).”
The Critical Role of Nonhuman Primates in Medical Research - White Paper
Friedman, H., Haigwood, N., Ator, N., Newsome, W., Allan, J. S., Golos, T. G., Kordower, J. H., Shade, R. E., Goldberg, M. E., Bailey, M. R., et al. (2017) · Pathogens and Immunity · doi:10.20411/pai.v2i3.186 · Cited by 108 · cited 2×
“Monkeys demonstrated high concordance for metabolic disorder (LR+ = 217.4), reflecting their physiological similarity to humans in lipid metabolism and endocrine regulation, and underscoring the relevance of non-human primates in modeling systemic metabolic responses (Bremer et al., 2011; Friedman et al., FIGURE 5 Net…”
InfluentialMechanisms of immune checkpoint inhibitor-mediated liver injury
Shojaie, L., Ali, M., Iorga, A., & Dara, L. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.10.003 · Cited by 98 · cited 1×
“This is consistent with the strong concordance observed in mice, which are widely used to model T cell–mediated hepatic injury and immune-related AE (Postow et al., 2018; Shojaie et al., 2021).”
Zhuang, P., Shou, Q., Lu, Y., Wang, G., Qiu, J., Wang, J., He, L., Chen, J., Jiao, J., & Zhang, Y. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.003 · Cited by 94 · cited 1×
“These clusters point to CNS-mediated appetite regulation involving hypothalamic neurocircuitry and suggest that hyperphagia may reflect direct drug effects on neural and hormonal satiety control (Morton et al., 2014; Zhuang et al., 2017; He et al., 2021; Wang et al., 2024; Qiu and Fu, 2025).”
Immune-mediated drug-induced liver injury: immunogenetics and experimental models
Gerussi, A., Natalini, A., Antonangeli, F., Mancuso, C., Agostinetto, E., Barisani, D., Di Rosa, F., Andrade, R., & Invernizzi, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094557 · Cited by 87 · cited 1×
“Mice demonstrated the strongest signal for immune-mediated hepatitis (LR+ = 462.4), reinforcing their well-established role in modeling immune–driven liver damage (Chakraborty et al., 2015; Gerussi et al., 2021).”
InfluentialTamaki, C., Nagayama, T., Hashiba, M., Fujiyoshi, M., Hizue, M., Kodaira, H., Nishida, M., Suzuki, K., Takashima, Y., Ogino, Y., et al. (2013) · The Journal of Toxicological Sciences · doi:10.2131/jts.38.581 · Cited by 79 · cited 3×
“Tamaki et al. (Tamaki et al., 2013) similarly examined 142 approved drugs in Japan using sensitivity, finding that infection, hematological, ocular, and injection-site reactions reached approximately 70% concordance, while cardiovascular, neurological, and cutaneous toxicities remained low ( < 30%).”
Serotonin Type 3 Receptor Genes: HTR3A, B, C, D, E
Niesler, B., Kapeller, J., Hammer, C., & Rappold, G. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.501 · Cited by 78 · cited 1×
“…(OPRM1), gut–brain axis regulators (GLP1R, GDF15), and excitability-related channels (CACNA1A), providing mechanistic support for these translational links (Niesler et al., 2008; Joy Lin et al., 2014; Sugino et al., 2014; Borner et al., 2020; Indelicato and Boesch, 2021; Huang et al., 2024).”
Use and importance of nonhuman Primates in metabolic disease research: current state of the field
Havel, P. J., Kievit, P., Comuzzie, A. G., & Bremer, A. A. (2017) · ILAR Journal · doi:10.1093/ilar/ilx031 · Cited by 75 · cited 1×
“Frontiers in Toxicology frontiersin.org 2017; Havel et al., 2017).”
5-HT receptor agonists modify epileptic seizures in three experimental models in rats
LOPEZMERAZ, M., GONZALEZTRUJANO, M., NERIBAZAN, L., HONG, E., & ROCHA, L. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.020 · Cited by 69
Lu, Z., Guo, Y., Xu, D., Xiao, H., Dai, Y., Liu, K., Chen, L., & Wang, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.029 · Cited by 69 · cited 1×
“These events often lack precise analogs in animal models, are subject to broad etiologic variability, or are under-detected due to behavioral and physiological differences across species (Van Norman, 2019; Lu et al., 2023; Wu et al., 2023).”
Mead, A. N., Amouzadeh, H. R., Chapman, K., Ewart, L., Giarola, A., Jackson, S. J., Jarvis, P., Jordaan, P., Redfern, W., Traebert, M., et al. (2016) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2016.05.002 · Cited by 67 · cited 1×
“For instance, fatigue is a multidimensional, highly individualized symptom experience that is influenced by disease context, treatment burden, and psychosocial factors, making it difficult to map onto conserved animal phenotypes (Mead et al., 2016).”
Polson, A. G., & Fuji, R. N. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01916.x · Cited by 66 · cited 1×
“Vomiting and fatigue often lack clear behavioral analogs in preclinical models (Polson and Fuji, 2012; Horn, 2014), while death and seizure are strongly influenced by multifactorial causes and inter-species variability (Wang et al., 2025), all of which reduces the generalizability of these…”
Chakraborty, M., Fullerton, A. M., Semple, K., Chea, L. S., Proctor, W. R., Bourdi, M., Kleiner, D. E., Zeng, X., Ryan, P. M., Dagur, P. K., et al. (2015) · Hepatology · doi:10.1002/hep.27764 · Cited by 64 · cited 1×
“Mice demonstrated the strongest signal for immune-mediated hepatitis (LR+ = 462.4), reinforcing their well-established role in modeling immune–driven liver damage (Chakraborty et al., 2015; Gerussi et al., 2021).”
InfluentialBiologic and checkpoint inhibitor‐induced liver injury: a systematic literature review
Shah, P., Sundaram, V., & Björnsson, E. (2020) · Hepatology Communications · doi:10.1002/hep4.1465 · Cited by 64 · cited 2×
“This difference likely reflects modality-specific mechanisms, where biologics more frequently trigger immune-driven responses compared to small molecules (Leach, 2013; Shah et al., 2020).”
Ye, C., Yang, H., Cheng, M., Shultz, L. D., Greiner, D. L., Brehm, M. A., & Keck, J. (2020) · The FASEB Journal · doi:10.1096/fj.202001203r · Cited by 62
5-HT recruits distinct neurocircuits to inhibit hunger-driven and non-hunger-driven feeding
He, Y., Cai, X., Liu, H., Conde, K., Xu, P., Li, Y., Wang, C., Yu, M., He, Y., Liu, H., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01220-z · Cited by 61 · cited 1×
“These clusters point to CNS-mediated appetite regulation involving hypothalamic neurocircuitry and suggest that hyperphagia may reflect direct drug effects on neural and hormonal satiety control (Morton et al., 2014; Zhuang et al., 2017; He et al., 2021; Wang et al., 2024; Qiu and Fu, 2025).”
Use of rabbit eyes in pharmacokinetic studies of intraocular drugs
Ahn, S. J., Hong, H. K., Na, Y. M., Park, S. J., Ahn, J., Oh, J., Chung, J. Y., Park, K. H., & Woo, S. J. (2016) · Journal of Visualized Experiments · doi:10.3791/53878 · Cited by 60
Bailey, J., & Balls, M. (2019) · BMC Medical Ethics · doi:10.1186/s12910-019-0352-3 · Cited by 51 · cited 2×
“Analytical inconsistencies also arise from the use of different statistical frameworks such as sensitivity, specificity, predictive values, or likelihood ratios, which can yield divergent conclusions (Monticello et al., 2017; Bailey and Balls, 2019; Giblin et al., 2021).”
T cells and monocyte-derived myeloid cells mediate immunotherapy-related hepatitis in a mouse model
Llewellyn, H. P., Arat, S., Gao, J., Wen, J., Xia, S., Kalabat, D., Oziolor, E., Virgen-Slane, R., Affolter, T., & Ji, C. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.06.037 · Cited by 47 · cited 1×
“…as immune-mediated organ injury such as checkpoint inhibitor-associated hepatitis, which have been qualitatively recapitulated in preclinical species, particularly in non-human primates and humanized mouse models (Sauna et al., 2018; Yong et al., 2020; Llewellyn et al., 2021; Kroenke et al., 2024).”
Boivin, A., & Deshaies, Y. (1995) · Metabolism · doi:10.1016/0026-0495(95)90072-1 · Cited by 45 · cited 1×
“Rats demonstrated high translatability for hypertriglyceridemia (112.7), in line with their known sensitivity to hepatic lipid accumulation and chronic metabolic stress (Boivin and Deshaies, 1995; Kucera and Cervinkova, 2014).”
InfluentialAnimal models of retinal vein occlusion
Khayat, M., Lois, N., Williams, M., & Stitt, A. W. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-22788 · Cited by 42 · cited 1×
“…such as retinal vein occlusion and macular oedema are also amenable to preclinical modeling, where laser-or occlusion-based paradigms in rodents and larger species reproduce hallmark vascular and edema phenotypes that can be quantified by fundus imaging, and histopathology (Khayat et al., 2017).”
Horn, C. C. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-3985-y · Cited by 38 · cited 1×
“Vomiting and fatigue often lack clear behavioral analogs in preclinical models (Polson and Fuji, 2012; Horn, 2014), while death and seizure are strongly influenced by multifactorial causes and inter-species variability (Wang et al., 2025), all of which reduces the generalizability of these…”
Improving reproducibility in animal research
Frommlet, F. (2020) · Scientific Reports · doi:10.1038/s41598-020-76398-3 · Cited by 37 · cited 1×
“These openly shared scientific resources directly support reproducibility in animal research (Frommlet, 2020).”
Prediction of clinical risks by analysis of preclinical and clinical adverse events
Clark, M. (2015) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2015.02.008 · Cited by 36 · cited 4×
“Clark et al. (Clark, 2015; Clark and Steger-Hartmann, 2018) and Giblin et al. (Giblin et al., 2021) applied likelihood ratios to identify endpoints such as arrhythmia, QT prolongation, and drug-specific antibody responses with strong translational value.”
InfluentialMabry, K., Hill, T., & Tolbert, M. K. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16057 · Cited by 32 · cited 1×
“For example, drug-induced gastrointestinal perforation has long been modeled in animals, especially dogs, and extensive work on NSAIDs has established reproducible frameworks linking this AE to human (Lascelles et al., 2005; Mabry et al., 2021).”
Jain, A. B., & Lai, V. (2024) · Diabetes Therapy · doi:10.1007/s13300-024-01628-0 · Cited by 32 · cited 1×
“These results underscore how systemic phenotypes with convergent pathophysiology (e.g., glucose or calcium dysregulation) may serve as shared translational markers across diverse drug modalities (Qamar et al., 2023; Jain and Lai, 2024).”
Vavers, E., Zvejniece, L., & Dambrova, M. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106771 · Cited by 30 · cited 1×
“…GRIN2B, GRIA1), key receptors (DRD1–3, OPRK1, OPRM1) and neuromodulatory signaling modulators (HTR1A, SIGMAR1), all of which are implicated in seizure susceptibility and propagation (López-Meraz et al., 2005; Bozzi and Borrelli, 2013; Vavers et al., 2023; Zhang et al., 2024; Ferraro et al., 2025).”
Gastrointestinal safety pharmacology in drug discovery and development
Al-Saffar, A., da Costa, A. N., Delaunois, A., Leishman, D. J., Marks, L., Rosseels, M.-L., & Valentin, J.-P. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-662-46943-9_12 · Cited by 29
Bussing, D., & K. Shah, D. (2020) · Journal of Pharmacokinetics and Pharmacodynamics · doi:10.1007/s10928-020-09713-0 · Cited by 29 · cited 1×
“This enrichment highlights the rabbit’s known ocular sensitivity and its established role as a preclinical model for ocular toxicity assessment, especially in biologic drug development (Ahn et al., 2016; Bussing and Shah, 2020; Sokolowski et al., 2024).”
Association of μ-opioid receptor gene (OPRM1) haplotypes with postoperative nausea and vomiting
Sugino, S., Hayase, T., Higuchi, M., Saito, K., Moriya, H., Kumeta, Y., Kurosawa, N., Namiki, A., & Janicki, P. K. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-3987-9 · Cited by 28 · cited 1×
“…(OPRM1), gut–brain axis regulators (GLP1R, GDF15), and excitability-related channels (CACNA1A), providing mechanistic support for these translational links (Niesler et al., 2008; Joy Lin et al., 2014; Sugino et al., 2014; Borner et al., 2020; Indelicato and Boesch, 2021; Huang et al., 2024).”
Nouveau, L., Buatois, V., Cons, L., Chatel, L., Pontini, G., Pleche, N., & Ferlin, W. G. (2021) · European Journal of Immunology · doi:10.1002/eji.202149181 · Cited by 25 · cited 1×
“For example, drug-induced cytokine release syndrome has been studies in a humanized mouse model with success measured by observing clinical signs and elevated human cytokines (IL-6, IFN-γ , TNF-α ) that mirror human CRS (Ye et al., 2020; Nouveau et al., 2021).”
Animal models for induction of diabetes and its complications
Qamar, F., Sultana, S., & Sharma, M. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01277-3 · Cited by 24 · cited 1×
“These results underscore how systemic phenotypes with convergent pathophysiology (e.g., glucose or calcium dysregulation) may serve as shared translational markers across diverse drug modalities (Qamar et al., 2023; Jain and Lai, 2024).”
Leach, M. W. (2013) · Toxicologic Pathology · doi:10.1177/0192623312451371 · Cited by 22 · cited 1×
“This difference likely reflects modality-specific mechanisms, where biologics more frequently trigger immune-driven responses compared to small molecules (Leach, 2013; Shah et al., 2020).”
Liu, X., Zhang, Y., Ward, L. D., Yan, Q., Bohnuud, T., Hernandez, R., Lao, S., Yuan, J., & Fan, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-95354-3 · Cited by 21 · cited 2×
“The foundational approach for the Safetyome was described previously (Liu et al., 2021; Liu et al., 2026), and has since been further enhanced in our research.”
Self-citationBurger, S., Stenger, T., Pierson, M., Sridhar, A., Huggins, M. A., Kucaba, T. A., Griffith, T. S., Hamilton, S. E., & Schuldt, N. J. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300061 · Cited by 21 · cited 1×
“…to humans (infections: Bio 10.7%, SM 6.9%; psychiatric disorders: SM 5.4%, Bio 2.2%), which may relate to differences in immune status, microbial exposure, and the scopes of behavioral assessments between animals and humans (Dinan and Cryan, 2017; Huggins et al., 2019; Burger et al., 2023).”
InfluentialGiblin, K. A., Basili, D., Afzal, A. M., Rosenbrier-Ribeiro, L., Greene, N., Barrett, I., Hughes, S. J., & Bender, A. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00311 · Cited by 18 · cited 7×
“Over the past two decades, numerous concordance studies have quantified cross-species translation across endpoints and datasets (Olson et al., 2000; Tamaki et al., 2013; Clark, 2015; Monticello et al., 2017; Clark and Steger-Hartmann, 2018; Giblin et al., 2021), as summarized in Supplementary Table 1.”
InfluentialProfound Perturbation in the Metabolome of a Canine Obesity and Metabolic Disorder Model
Qu, W., Chen, Z., Hu, X., Zou, T., Huang, Y., Zhang, Y., Hu, Y., Tian, S., Wan, J., Liao, R., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.849060 · Cited by 18
Exploring rabbit as a nonrodent species for general toxicology studies
Sokolowski, K., Turner, P. V., Lewis, E., Wange, R. L., & Fortin, M. C. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae022 · Cited by 17 · cited 1×
“This enrichment highlights the rabbit’s known ocular sensitivity and its established role as a preclinical model for ocular toxicity assessment, especially in biologic drug development (Ahn et al., 2016; Bussing and Shah, 2020; Sokolowski et al., 2024).”
Joy Lin, Y.-M., Hsu, C.-D., Hsieh, H.-Y., Tseng, C.-C. A., & Sun, H. S. (2014) · Journal of Human Genetics · doi:10.1038/jhg.2014.89 · Cited by 16 · cited 1×
“…(OPRM1), gut–brain axis regulators (GLP1R, GDF15), and excitability-related channels (CACNA1A), providing mechanistic support for these translational links (Niesler et al., 2008; Joy Lin et al., 2014; Sugino et al., 2014; Borner et al., 2020; Indelicato and Boesch, 2021; Huang et al., 2024).”
Humanized mouse as a tool to predict immunotoxicity of human biologics
Yong, K. S. M., Her, Z., Tan, S. Y., Tan, W. W. S., Liu, M., Lai, F., Heng, S. M., Fan, Y., Chang, K. T. E., Wang, C.-I., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.553362 · Cited by 13
Wu, T., Zhou, K., Hua, Y., Zhang, W., & Li, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1164487 · Cited by 12 · cited 1×
“These events often lack precise analogs in animal models, are subject to broad etiologic variability, or are under-detected due to behavioral and physiological differences across species (Van Norman, 2019; Lu et al., 2023; Wu et al., 2023).”
Kroenke, M. A., Manning, M. S., de Zafra, C. L. Z., Zhang, X., Cook, K. D., Archer, M., Lolkema, M. P., Wang, J., Hoofring, S. A., Saini, G., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1345473 · Cited by 12 · cited 1×
“…as immune-mediated organ injury such as checkpoint inhibitor-associated hepatitis, which have been qualitatively recapitulated in preclinical species, particularly in non-human primates and humanized mouse models (Sauna et al., 2018; Yong et al., 2020; Llewellyn et al., 2021; Kroenke et al., 2024).”
Considerations in the extrapolation of drug toxicity between humans and dogs
Martinez, M. N., Mochel, J. P., & Pade, D. (2020) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2020.05.005 · Cited by 9 · cited 1×
“Their larger body size and ability to capture behavioral endpoints (e.g., feeding behavior) enhance their sensitivity for metabolic AEs (Martinez et al., 2020; Qu et al., 2022).”
Wright, P. S. R., Briggs, K. A., Thomas, R., Smith, G. F., Maglennon, G., Mikulskis, P., Chapman, M., Greene, N., Phillips, B. U., & Bender, A. (2023) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2022.105308 · Cited by 8 · cited 1×
“Animal and human studies were deemed comparable if the exposure difference was within one log-unit, indicated by | Δ log10Cmax| or | Δ log10AUC| ≤ 1 (Wright et al., 2023).”
Moxon, M., Beekhuijzen, M., Hannas, B., Manton, J., French, J., & Malley, L. (2023) · Reproductive Toxicology · doi:10.1016/j.reprotox.2023.108386 · Cited by 7
Mapping GABAergic projections that mediate feeding
Wang, J., O’Reilly, M., Cooper, I. A., Chehrehasa, F., Moody, H., & Beecher, K. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105743 · Cited by 7 · cited 1×
“These clusters point to CNS-mediated appetite regulation involving hypothalamic neurocircuitry and suggest that hyperphagia may reflect direct drug effects on neural and hormonal satiety control (Morton et al., 2014; Zhuang et al., 2017; He et al., 2021; Wang et al., 2024; Qiu and Fu, 2025).”
Wang, Z., Mei, H., Song, B., & Shi, Z. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110638 · Cited by 6
GPCRs in hypothalamic neurons and their roles in controlling food intake and metabolism
Qiu, T., & Fu, O. (2025) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2025.1536577 · Cited by 4 · cited 1×
“These clusters point to CNS-mediated appetite regulation involving hypothalamic neurocircuitry and suggest that hyperphagia may reflect direct drug effects on neural and hormonal satiety control (Morton et al., 2014; Zhuang et al., 2017; He et al., 2021; Wang et al., 2024; Qiu and Fu, 2025).”
Modulation of mu-opioid receptor function alters electroshock seizure responses in mice
Ferraro, T. N., DeChiara, J., Chen, R., Chen, Y., Doyle, G. A. R., & Buono, R. J. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110427 · Cited by 3 · cited 1×
“…GRIN2B, GRIA1), key receptors (DRD1–3, OPRK1, OPRM1) and neuromodulatory signaling modulators (HTR1A, SIGMAR1), all of which are implicated in seizure susceptibility and propagation (López-Meraz et al., 2005; Bozzi and Borrelli, 2013; Vavers et al., 2023; Zhang et al., 2024; Ferraro et al., 2025).”
Koshman, Y. E., Kohnken, R., Logan, M. R., Mittelstadt, S. W., & Foley, C. M. (2024) · Toxicological Sciences · doi:10.1093/toxsci/kfae002 · Cited by 2 · cited 1×
“%) and “vascular disorders” (11.4%), reflecting their known sensitivity to hematologic and cardiovascular toxicities and underscoring their utility in evaluating related safety risks in preclinical studies (Clark and Steger-Hartmann, 2018; Koshman et al., 2024).”
InfluentialLiu, X., Chen, Y.-W., Xu, X., Smith, D., & Fan, F. (2026) · Toxicological Sciences · doi:10.1093/toxsci/kfag021 · Cited by 1 · cited 2×
“The foundational approach for the Safetyome was described previously (Liu et al., 2021; Liu et al., 2026), and has since been further enhanced in our research.”
Research works printed but not linked: 1
- Shreffler, 2024, Diagnostic testing accuracy: sensitivity, specificity, predictive values and likelihood ratios
Cited by
Artificial Intelligence Across the Drug Development Lifecycle
Demyashkin, G. A., Алексеевич, П. М., Zyryanov, S., Yavorskiy, A., Shegai, P., & Kaprin, A. (2026) · Medical Sciences · doi:10.3390/medsci14020248 · Cited by 6
“This pattern carries a direct implication for AI, because a model trained predominantly on rat hepatotoxicity data will learn to predict rat hepatotoxicity [191].”
Domingo, J. L. (2026) · Qeios · doi:10.32388/lrqpsd.2
Filipova, D., Fox, L., Goßmann, M., Herrmann, K., Knight, A., Lickiss, B., Maaß, C., Neumann, G., Ritskes-Hoitinga, M. J., & Zietek, T. (2026) · NAM journal. · doi:10.1016/j.namjnl.2026.100136
Groenen, P. M. A. (2026) · NAM journal. · doi:10.1016/j.namjnl.2026.100135
Metadata
- Authors
- Liu, X., & Fan, F.
- Affiliations
- Johnson & Johnson (United States) (US)
- Corresponding author
- Liu, Xin
- Venue
- Frontiers in Toxicology
- Publisher
- Frontiers Media SA
- Published
- 2026-04-02
- Volume
- 8
- Pages
- 1731947-1731947
- ISSN
- 2673-3080 (ISSN-L)
- PMC
- PMC13082757
- OpenAlex
- W7147433783
- Semantic Scholar
- 3f7e708816873f6ec98fa5233bbeb1b8421dd228
- Cited by
- 4
- References
- 81
- Citations by year
- 2026: 4
- FWCI
- 26.68
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Toxicology (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- drug safety, small molecules, biologics, likelihood ratios, prevalence bias, 3Rs, human risk assessment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.